Navigation Links
FDA Advisors Declare 'FDA Science and Mission at Risk'
Date:1/29/2008

be answered and everything slows down. Dr. Cassell and her subcommittee have provided additional insight into why FDA needs more resources to meet the needs of the seriously ill."

--Diane Dorman, Vice President, Public Policy, National Organization for Rare Disorders

Americans rely on the FDA's scientific competence, every day and in many ways. Consumers want and need a stronger FDA to assure safe foods, drugs, biologics, and devices. It is encouraging that members of the FDA Science Board, along with a number of external advisors, have so unequivocally come down on the side of more resources."

---Diana Zuckerman, President, National Research Center for Women & Families

"Consumers and industry are working together with FDA to improve the safety of America's food supply. It is frustrating that FDA does not have the scientific capacity and personpower to get the job done."

--Caroline Smith DeWaal, Center for Science in the Public Interest

"Industry is committed to a safe food supply based on scientific principles for management, control and targeting. We welcome the conclusion of this report: science is FDA's most important tool and it cannot be fully effective without the resources to support science, hire trained people, and use information technology to support food safety."

---Honorable Cal Dooley, Grocery Manufacturer's Association

"Americans expect 'gold standard' FDA oversight of innovations like nanotechnology to ensure that benefits are available promptly and the products are safe, but FDA can't do this without 'gold standard' scientific capacity and expertise to ask the right questions and make prompt, rigorous reviews. As the FDA Science Board report makes clear, FDA's science base has declined to a point that jeopardizes the ability of patients and consumers to capitalize on America's enormous investment in technological innovation. FDA's eroded science base is a 'penny wise and pound foolish
'/>"/>

SOURCE Alliance for a Stronger FDA
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Lincoln Financial Advisors to Provide Exclusive Services to American Osteopathic Association Members
2. FDA Advisors Declare FDA Science and Mission at Risk
3. Perceptive Informatics Appoints Medical Imaging Scientific Advisors
4. NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo
5. Landauer, Inc. Declares Regular Cash Dividend
6. Weight Watchers Declares Quarterly Dividend
7. Ventas Declares Regular Quarterly Dividend of $0.475 Per Share
8. P.A.C.K. Week Declared in Support of Fruits & Veggies-More Matters Month
9. Abbott Declares 335th Consecutive Quarterly Dividend
10. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
11. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... June 20, 2013 This ... focuses mainly on the oral and injectable ... report enumerates the various formulation technologies involved ... and advantages of specific technologies. Wherever possible, ... been discussed as proof of validation along ...
(Date:6/20/2013)... Beverly Hills, CA (PRWEB) June 20, 2013 ... David M. Amron, has been named by The Patient’s ... as an expert in liposuction, Dr. Amron will now ... Patient’s Guide. The Patient's Guide sees over one million ... provides information and articles related to plastic surgery and ...
(Date:6/20/2013)... Novatus Contract Management , the ... next release of upgrades and enhancements will be available ... system more robust, but continue to add investment value ... Online Negotiation Portal™ Interface enhancements – ... Portal from the outside. , Company Relationships ...
(Date:6/20/2013)... 20, 2013 Presenting at the ... society president and keynote speaker Dr. Rod ... future of rhinoplasty (plastic surgery of the nose) ... from across the nation. In his address, Dr. ... rhinoplasty to current open-technique rhinoplasty that reduces risk ...
(Date:6/20/2013)... weight may not reverse the damage that has been done ... even moderate weight loss can have a dramatic effect on ... within normal and healthy weight ranges is ideal, starting with ... shown to help relieve joint pain, as well as help ... have revealed that a weight loss of 11 pounds decreases ...
Breaking Medicine News(10 mins):Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 2Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 3Health News:Novel Drug Delivery Systems Market (NDDS): Formulations (Oral & Injectable) Analysis in Research Report at RnRMarketResearch.com 4Health News:Liposuction Guru, Dr. David Amron, Receives Award From The Patient’s Guide 2Health News:Novatus Contract Management Newest Enhancements and Upgrades to be Available July 1 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 2Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 3Health News:Dr. Rod J. Rohrich Delivers Keynote Address on the Future of Rhinoplasty 4Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Diet Plans, Now Capable of Helping Patient’s Avoid The Risk of Arthritis With Natural Weight Loss 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Diet Plans, Now Capable of Helping Patient’s Avoid The Risk of Arthritis With Natural Weight Loss 3
... SPRING, Md., Feb. 28 Celebrity chef Emeril,Lagasse joins ... top,quality food with viewers this summer in the new ... 24/7 eco-lifestyle,television network, is set to launch in June ... premiering throughout the summer, including,EMERIL GREEN (wt) which will ...
... TDP-43 mutations expose potential therapeutic target, experts say , , ... a new, yet rare, genetic mutation in the development ... only exposes a potential therapeutic target for treating the ... mutation sets in motion the mechanism that causes many ...
... and men are completely satisfied with the time they spend ... study published in the Journal of Family Issues. , ... be more time pressured than those who work part time ... professor of sociology at Kent State University. , In ...
... will Integrate IDC,s X1590 into the First Standardized ... ... /PRNewswire-FirstCall/ - IDC (Imaging Dynamics Company,Ltd.) (TSX: IDL), the global ... announced that Halifax Biomedical has selected,IDC,s X1590 as the DR ...
... PRINCETON, N.J., Feb. 28 Organizations,representing the state,s ... funding cuts proposed for hospital care for New ... $33 billion state spending plan for 2009, released,Tuesday, ... with funding of $608,million compared with current funding ...
... unlocked some of the mysteries of how the developing ... A present in the maternal blood stream. Their results ... Journal of Biological Chemistry. , The researchers studied ... formation of vitamin A stores in the body, during ...
Cached Medicine News:Health News:Emeril Lagasse and Planet Green Partner with Whole Foods Market(R) on Innovative New Series 2Health News:Emeril Lagasse and Planet Green Partner with Whole Foods Market(R) on Innovative New Series 3Health News:New Gene for Lou Gehrig's Disease Identified 2Health News:New Gene for Lou Gehrig's Disease Identified 3Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 3Health News:Hospital Groups United in Opposition to Charity Care Cuts 2Health News:Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development 2Health News:Rutgers researchers unlock mysteries of vitamin A metabolism during embryonic development 3
(Date:6/19/2013)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... of Medicine ( NEJM ) published results online ... Bruton,s tyrosine kinase (BTK) inhibitor ibrutinib in patients with ... (SLL). Ibrutinib was shown to be safe and effective ... patients who were at high-risk due to factors such ...
(Date:6/19/2013)... 2013 A decade-long JDRF-funded study led by ... Germany , is providing a deeper ... of developing type 1 diabetes (T1D), highlighting the importance ... The study, "Seroconversion to Multiple Islet Autoantibodies and Risk ... in The Journal of the American Medical Association ...
(Date:6/19/2013)... June 19, 2013  Finesse Solutions, Inc, a ... sciences process applications, announced the launch of its ... cell culture and fermentation.  The 3L glass vessels ... of Finesse bioreactors and are designed to optimize ... are fully compatible with all Finesse G3Lab controllers, ...
Breaking Medicine Technology:Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 2Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 3Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 4Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 5Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine 6New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 2New Data on Islet Autoantibodies in Young Children Defines Early Type 1 Diabetes Development 3Finesse Solutions Launches Next Generation SmartGlass 3L Bioreactors for Cell Culture and Fermentation 2
... Inc.,(Nasdaq: NVAX ) today announced that the Company ... the Phase I/IIa human clinical,trial of Novavax,s H5N1 pandemic ... August 26, 2008., The call will be hosted ... and other members of senior management, including,Chief Medical Officer, ...
... Johnson & Johnson Pharmaceutical,Research & Development, ... Food,and Drug Administration (FDA) requires additional information ... Application (NDA) for DORIBAX(TM),(doripenem for injection) for ... nosocomial pneumonia (NP), including ventilator-associated,pneumonia (VAP)., ...
Cached Medicine Technology:Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 2FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 3FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 4FDA Requires Additional Information on DORIBAX for Treatment of Hospital-Acquired Pneumonia 5